Dr André-Guy Martin speaks to ecancer at EMUC 2019 in Vienna about an improved regimen of hormone therapy.
He outlines a recent study which showed little difference in overall survival if you used a long term hormone therapy regimen.
Dr Martin suggests a shorter regimen for those patients who do not tolerate the therapy particularly well.